Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity
Details for Australian Patent Application No. 2003208000 (hide)
International Classifications
Event Publications
17 July 2003 Complete Application Filed
Priority application(s): RM2002A000049 30.01.02 IT
18 September 2003 Application Open to Public Inspection
Published as AU-B-2003208000
29 January 2009 Assignment before Grant
Burioni, Roberto The application has been assigned to GENERAL ANTIBODIES AND BIOTECHNOLOGIES S.R.L. (GA S.R.L)
20 May 2010 Application Accepted
Published as AU-B-2003208000
16 September 2010 Standard Patent Sealed
1 March 2012 Assignment Registered
General Antibodies and Biotechnologies S.R.L. (GA Assignments Registered S.R.L) The patent has been assigned to Pomona Ricerca S.r.l.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser